ACADIA Pharmaceuticals Inc. news

   Watch this stock
Showing stories 1 - 10 of about 80   

Articles published

ACAD 26.79 -1.45 (-5.13%)
price chart
Stocks in the Spotlight: Sprint Corporation (S), ACADIA Pharmaceuticals Inc ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) jumped 2.80 percent to $28.24 on Friday. The company's CEO Uli Hacksell last week sold 30,000 shares of ACAD stock at an average price of $27.36 per share.
Today's Watch List: MetLife (NYSE:MET), ACADIA Pharmaceuticals Inc ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CEO Uli Hacksell unloaded 30,000 shares of the company's stock in a transaction that occurred on Wednesday, September 10th.
Related articles »  
Options Radar: ACADIA Pharmaceuticals, Weibo Corp, and First Solar
Option traders have taken a shine to drug maker ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Chinese social media concern Weibo Corp (ADR) (NASDAQ:WB), and alternative energy firm First Solar, Inc. (NASDAQ:FSLR).
Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio ...
The stock oscillated between $22.12 and $22.76 during the session. Over the last one month and over the past three months, ACADIA Pharmaceuticals Inc.'s shares have surged 11.46% and 17.52%, respectively. However, the stock has lost 9.68% since the ...
Related articles »  
Pre-market Gainers: Rocket Fuel Inc. (NASDAQ:FUEL), ACADIA ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders on 2 ...
Insider Selling: ACADIA Pharmaceuticals CEO Sells 30000 Shares of Stock ...
ACADIA Pharmaceuticals logo ACADIA Pharmaceuticals (NASDAQ:ACAD) CEO Uli Hacksell sold 30,000 shares of the company's stock on the open market in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average ...
ACADIA Pharmaceuticals CEO Uli Hacksell Sells 30000 Shares (ACAD)  Watch List News (press release)
Investor News: Inovio Pharmaceuticals, Inc. (NYSEMKT:INO), Alcatel-Lucent ...  Markets Insider
Related articles »  
Latest Top News Stories: ACADIA Pharmaceuticals Inc. (ACAD), MGM Resorts ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) soared 10.97% following news that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to NUPLAZID´┐Ż (pimavanserin) for the treatment of Parkinson's disease ...
ACADIA Pharmaceuticals Receives FDA Breakthrough Therapy Designation for ...  MarketWatch
Stocks To Watch: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Gold Fields ...  Market News Call
Related articles »  
What's Leading Biotechs Higher? - ACADIA Pharmaceuticals Inc. (ACAD ...
Biotech stocks continue to make noteworthy gains following U.S. stocks higher on M&A activity and a report showing an increase in optimism among U.S.
5 Stocks under Wall Street's Radar: ACADIA Pharmaceuticals Inc. (NASDAQ ...
On 15 AUG ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CEO Uli Hack sell unloaded 15,000 shares of the company's stock on the open market in a transaction dated Friday, August 15th.
Related articles »  
Trending Tickers In Focus: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Alnylam ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders, ...
Related articles »